In 2014, it was also approved for the treatment of obesity, whereas tirzepatide was first approved by the FDA in 2022 for the treatment of T2DM
Studies are ongoing into the reasons for this, but many scientists believe there is a link between low glutathione levels and cell death
Patients should be alert to warning signs requiring urgent medical attention, including severe abdominal pain (especially if radiating to the back), persistent vomiting, or signs of gallbladder disease or pancreatitis
A medical cooling case is a worthwhile investment if you frequently transport your medication
Providers prescribing these compounds must hold appropriate DEA prescriber registration, and the dispensing pharmacy must hold a valid DEA registration authorizing Schedule IIV controlled substances
See dosage information before using